Legend Biotech Corp
NASDAQ:LEGN
Legend Biotech Corp
Pre-Tax Income
Legend Biotech Corp
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Legend Biotech Corp
NASDAQ:LEGN
|
Pre-Tax Income
-$520.1m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-218%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Pre-Tax Income
$6.3B
|
CAGR 3-Years
23%
|
CAGR 5-Years
4%
|
CAGR 10-Years
2%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Pre-Tax Income
$1.1B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-16%
|
|
Amgen Inc
NASDAQ:AMGN
|
Pre-Tax Income
$4.3B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-2%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Pre-Tax Income
$4.4B
|
CAGR 3-Years
12%
|
CAGR 5-Years
49%
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Pre-Tax Income
$4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
10%
|
CAGR 10-Years
18%
|
See Also
What is Legend Biotech Corp's Pre-Tax Income?
Pre-Tax Income
-520.1m
USD
Based on the financial report for Dec 31, 2023, Legend Biotech Corp's Pre-Tax Income amounts to -520.1m USD.
What is Legend Biotech Corp's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
-218%
Over the last year, the Pre-Tax Income growth was -17%. The average annual Pre-Tax Income growth rates for Legend Biotech Corp have been -19% over the past three years , -218% over the past five years .